Avila-Vergara MA, Peraza-Garay FJ, Meraz-Cruz N, Hernandez-Guerrero C, Palacios-Gonzalez B, Vadillo-Ortega F

Idioma: Ingles.
Referencias bibliográficas: 44
Paginas: 96-102
Archivo PDF: 105.33 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Mor G, Cardenas I, Abrahams V, Guller S. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci. 2011;1221:80-7.

2. Jabbour HN, Sales KJ, Catalano RD, Norman JE. Inflammatory pathways in female reproductive health and disease. Reproduction. 2009;138:903-19.

3. Weiss G, Goldsmith LT, Taylor RN, Bellet D, Taylor HS. Inflammation in reproductive disorders. Reprod Sci. 2009;16:216-29.

4. Zegers-Hochschild F, Adamson GD, Dyer S, et al. The international glossary on infertility and fertility care, 2017. Fertil Steril. 2017;108:393-406.

5. Kolte AM, Bernardi LA, Christiansen OB, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod. 2015;30:495-8.

6. Casanova JL, Abel L, Quintana-Murci L. Human TLRs and IL- 1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics. Annu Rev Immunol. 2011; 29:447-91.

7. Imakawa K, Chang KT, Christenson RK. Pre-implantation conceptus and maternal uterine communications: molecular events leading to successful implantation. J Reprod Dev. 2004;50:155-69.

8. De los Santos MJ, Mercader A, Francés A, et al. Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development. Biol Reprod. 1996;54:563-74.

9. Sarno J, Schatz F, Huang SJ, Lockwood C, Taylor HS. Thrombin and interleukin-1beta decrease HOX gene expression in human first trimester decidual cells: implications for pregnancy loss. Mol Hum Reprod. 2009;15:451-7.

10. Giannubilo SR, Landi B, Pozzi V, et al. The involvement of inflammatory cytokines in the pathogenesis of recurrent miscarriage. Cytokine. 2012;58:50-6.

11. Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today. 1991; 12:404-10.

12. Lennard AC. Interleukin-1 receptor antagonist. Crit Rev Immunol. 1995;15:77-105.

13. Arend WP, Gabay C. Physiologic role of interleukin-1 receptor antagonist. Arthritis Res. 2000;2:245-8.

14. Aksentijevich I, Masters SL, Ferguson PJ, et al. An autoinflammatory disease with deficiency of the interleukin 1-receptor antagonist. N Engl J Med. 2009;360:2426-37.

15. Witkin SS, Gerber S, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis. 2002;34:204-9.

16. Patterson D, Jones C, Hart I, et al. The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region. Genomics. 1993;15:173-6.

17. Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 1993;91:403-4.

18. Perni SC, Vardhana S, Tuttle SL, et al. Fetal interleukin-1 receptor antagonist gene polymorphism, intra-amniotic interleukin- 1beta levels, and history of spontaneous abortion. Am J Obstet Gynecol. 2004;191:1318-23.

19. Unfried G, Tempfer C, Schneeberger C, et al. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril. 2001;75:683-7.

20. Witkin SS, Vardhana S, Yih M, et al. Polymorphism in intron 2 of the fetal interleukin-1 receptor antagonist genotype influences midtrimester amniotic fluid concentrations of interleukin- 1beta and interleukin-1 receptor antagonist and pregnancy outcome. Am J Obstet Gynecol. 2003;189:1413-7.

21. Dai MZ, Pan YQ, Xu DP, et al. IL-1 receptor antagonist gene polymorphism in idiopathic recurrent spontaneous abortion in a chinese han population. Int J Immunogenet. 2010;37:393-6.

22. Levrant S, Coulam CB, Jeyendran RS. Interleukin 1 receptor antagonist gene polymorphisms are not risk factors for recurrent pregnancy loss: evaluation of couples. Am J Reprod Immunol. 2008;60:224-8.

23. Genç MR, Gerber S, Nesin M, Witkin SS. Polymorphism in the interleukin-1 gene complex and spontaneous preterm delivery. Am J Obstet Gynecol. 2002;187:157-63.

24. Prutsch N, Fock V, Haslinger P, et al. The role of interleukin-1β in human trophoblast motility. Placenta. 2012;33:696-703.

25. Flamigni C, Bulletti C, Polli V, et al. Factors regulating interaction between trophoblast and human endometrium. Ann N Y Acad Sci. 1991;622:176-90.

26. Kariya M, Kanzaki H, Takakura K, et al. Interleukin-1 inhibits in vitro decidualization of human endometrial stromal cells. J Clin Endocrinol Metab. 1991;73:1170-4.

27. Frank GR, Brar AK, Jikihara H, Cedars MI, Handwerger S. Interleukin- 1 beta and the endometrium: an inhibitor of stromal cell differentiation and possible autoregulator of decidualization in humans. Biol Reprod. 1995;52:184-91.

28. Kniss DA, Zimmerman PD, Garver CL, Fertel RH. Interleukin-1 receptor antagonist blocks interleukin-1-induced expression of cyclooxygenase-2 in endometrium. Am J Obstet Gynecol. 1997;177:559-67.

29. Simón C, Valbuena D, Krüssel J, et al. Interleukin-1 receptor antagonist prevents embryonic implantation by a direct effect on the endometrial epithelium. Fertil Steril. 1998;70:896-906.

30. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol. 1995;99:303-10.

31. Dewberry R, Holden H, Crossman D, Francis S. Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20: 2394-400.

32. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol. 1998;28:2598-602.

33. Buchs N, di Giovine FS, Silvestri T, et al. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun. 2001;2: 222-8.

34. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol. 1998;47:195-8.

35. Arend WP. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 2002;13:323-40.

36. Wang J, Wu F, Xie Q, et al. Anakinra and etanercept prevent embryo loss in pregnant nonobese diabetic mice. Reproduction. 2015;149:377-84.

37. Nguyen DP, Genc M, Vardhana S, et al. Ethnic differences of polymorphisms in cytokine and innate immune system genes in pregnant women. Obstet Gynecol. 2004;104:293-300.

38. Xu DP, Ruan YY, Pan YQ, et al. VNTR polymorphism of human IL1RN in Chinese Han and she ethnic populations. Int J Immunogenet. 2011;38:13-6.

39. Karhukorpi J, Laitinen T, Kivelä H, Tiilikainen A, Hurme M. IL-1 receptor antagonist gene polymorphism in recurrent spontaneous abortion. J Reprod Immunol. 2003;58:61-7.

40. Nair RR, Khanna A, Singh K. Association of interleukin 1 receptor antagonist (IL1RN) gene polymorphism with recurrent pregnancy loss risk in the north Indian population and a metaanalysis. Mol Biol Rep. 2014;41:5719-27.

41. Gremlich S, Fratta S, Rebellato E, et al. Interleukin-1 receptor antagonist gene (IL-1RN) polymorphism is a predictive factor of clinical pregnancy after IVF. Hum Reprod. 2008; 23:1200-6.

42. Linjawi S, Li TC, Laird S, Blakemore A. Interleukin-1 receptor antagonist and interleukin-1 beta polymorphisms in women with recurrent miscarriage. Fertil Steril. 2005;83:1549-52.

43. Choi YK, Kwak-Kim J. Cytokine gene polymorphisms in recurrent spontaneous abortions: a comprehensive review. Am J Reprod Immunol. 2008;60:91-110.

44. Saravelos SH, Li TC. Unexplained recurrent miscarriage: how can we explain it? Hum Reprod. 2012;27:1882-6